Skip to content

Anika Therapeutics ANIK Change in Other Assets

Change in Other Assets at other companies

Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
$4.54M-12.8%
Xtant Medical Holdings logo
Xtant Medical HoldingsXTNT
-$152K+45.7%
Globus Medical logo
Globus MedicalGMED
-$6.94M-53.1%
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
$1.66M-67.7%
Avanos Medical logo
Avanos MedicalAVNS
$2.4M+900%
Sanara MedTech Inc. logo
Sanara MedTech Inc.SMTI
-$166.16K-407%

Other financials

Income statement

See full
Revenue$29.6M+13.2%
Net income-$5.1M-3.8%

Balance sheet

See full
Cash & equivalents$41.0M-23.1%
Total debt$25.7M+1.2%
Total equity$133.9M-9.8%
Total assets$179.4M-5.9%

Cash flow

See full
Operating cash flow-$4.8M-3,628%
CapEx$1.4M-49.3%
Free cash flow-$6.3M-112%

Valuation

See full
Market cap$204.37M+31.6%
Enterprise value$189.09M+48.7%
P/S1.8×+0.1×

Profitability

See full
Net margin-9.8%-4.4pp
FCF margin0.9%

Returns & leverage

See full
Return on equity-8%-3.4pp
Debt / equity0.2×0.0×
Current ratio4.5×-1.3×

Where this comes from

Reported directly by Anika Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Anika Therapeutics's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Anika Therapeutics's change in other assets?
Anika Therapeutics (ANIK) reported change in other assets of $1.73M in Q1 2026.
How has Anika Therapeutics's change in other assets changed year-over-year?
Anika Therapeutics's change in other assets increased by 751.2% year-over-year, from $203K to $1.73M.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.